Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Pinotblancon Jan 03, 2019 9:54pm
92 Views
Post# 29184501

RE:RE:RE:Why Aurora Cannabis Will Be A Major Breakout Story Of 2019

RE:RE:RE:Why Aurora Cannabis Will Be A Major Breakout Story Of 2019
GeorgeOU812 wrote: Well said, Pinotblanc. Deals are nice and exciting at first, but as we've seen quite often with other stocks (ie: Tilray) the gains from new deals are not sustainable unless you have a recipe for longterm profits. It's the classic dilemna, do you focus on immediate brief success or on future longterm success. I think longterm is the way to go.

Pinotblanc wrote: So, beside a deal that will boost the price temporarely, they need to perform related to their guidance and it will take quarter results.




Right, though I could sell along the way after a too big increase in price to buy back at a lower price. Also, I will not begin to troll a group because I sold to pump after I bought. I put all those trols on ignore. 
Bullboard Posts